BINDREN

Serial Number 77429983
606

Registration Progress

Application Filed
Mar 24, 2008
Under Examination
Dec 16, 2008
Approved for Publication
Sep 3, 2008
Published for Opposition
Sep 23, 2008
Registered

Trademark Image

BINDREN

Basic Information

Serial Number
77429983
Filing Date
March 24, 2008
Published for Opposition
September 23, 2008
Abandonment Date
January 16, 2012
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jan 16, 2012
Classes
005

Rights Holder

Mitsubishi Tanabe Pharma Corporation

03
Address
2-6-18, Kitahama
Chuo-ku, Osaka 5418505
JP

Ownership History

Mitsubishi Tanabe Pharma Corporation

Original Applicant
03
Osaka-shi, Osaka JP

Mitsubishi Tanabe Pharma Corporation

Owner at Publication
03
Chuo-ku, Osaka JP

Legal Representation

Attorney
Sarah Anne Keefe

USPTO Deadlines

All Deadlines Cleared

All 5 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

35 events
Date Code Type Description
Jan 17, 2012 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Jan 16, 2012 ABN6 S ABANDONMENT - NO USE STATEMENT FILED
May 26, 2011 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 25, 2011 EX5G S SOU EXTENSION 5 GRANTED
May 23, 2011 EEXT I SOU TEAS EXTENSION RECEIVED
May 23, 2011 EXT5 S SOU EXTENSION 5 FILED
Dec 9, 2010 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 8, 2010 EX4G S SOU EXTENSION 4 GRANTED
Dec 3, 2010 EEXT I SOU TEAS EXTENSION RECEIVED
Dec 3, 2010 EXT4 S SOU EXTENSION 4 FILED
Jun 2, 2010 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 1, 2010 EX3G S SOU EXTENSION 3 GRANTED
May 26, 2010 EEXT I SOU TEAS EXTENSION RECEIVED
May 26, 2010 EXT3 S SOU EXTENSION 3 FILED
Oct 26, 2009 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Oct 26, 2009 EX2G S SOU EXTENSION 2 GRANTED
Oct 9, 2009 EEXT I SOU TEAS EXTENSION RECEIVED
Oct 9, 2009 EXT2 S SOU EXTENSION 2 FILED
Apr 28, 2009 EEXT I SOU TEAS EXTENSION RECEIVED
Apr 28, 2009 EXT1 S SOU EXTENSION 1 FILED
Apr 28, 2009 EX1G S SOU EXTENSION 1 GRANTED
Dec 16, 2008 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT
Sep 23, 2008 PUBO A PUBLISHED FOR OPPOSITION
Sep 3, 2008 NPUB O NOTICE OF PUBLICATION
Aug 15, 2008 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED
Aug 14, 2008 ALIE A ASSIGNED TO LIE
Aug 8, 2008 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 22, 2008 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 22, 2008 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 22, 2008 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 26, 2008 DOCK D ASSIGNED TO EXAMINER
Jun 26, 2008 CNRT R NON-FINAL ACTION WRITTEN
Jun 26, 2008 GNRT F NON-FINAL ACTION E-MAILED
Jun 26, 2008 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 27, 2008 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Pharmaceutical preparations, namely, preparations for the treatment, control and prevention of human disorders and diseases resulting from hyperphosphatemia, hyperlipidemia, hypercholestrolemia, hyperparathyroidism, kidney dysfunction, and neurological, genetic, cardiovascular, gastrointestinal, urological, metabolic, diabetic, allergy, obesity, and insulin resistance syndromes and conditions
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005